AA
AlphaCentric Advisors’s Puma Biotechnology PBYI Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q1 | – | Sell |
-50,000
| Closed | -$212K | – | 216 |
|
2022
Q4 | $212K | Sell |
50,000
-365,000
| -88% | -$1.54M | 0.21% | 129 |
|
2022
Q3 | $984K | Buy |
+415,000
| New | +$984K | 1.01% | 24 |
|
2021
Q4 | $1.22M | Buy |
400,000
+251,500
| +169% | +$765K | 0.35% | 21 |
|
2021
Q3 | $1.04M | Buy |
148,500
+108,500
| +271% | +$761K | 0.26% | 27 |
|
2021
Q2 | $367K | Buy |
40,000
+20,000
| +100% | +$184K | 0.1% | 80 |
|
2021
Q1 | $194K | Buy |
20,000
+10,500
| +111% | +$102K | 0.07% | 95 |
|
2020
Q4 | $97K | Buy |
+9,500
| New | +$97K | 0.04% | 140 |
|